CDC. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus . MMWR 1989;;38 (no.
(S-5)
).
Oxtoby MJ. Perinatally acquired human immunodeficiency virus infection . Pediatr Infect Dis J 1990;;9:609-19.
Scott GB, Hutto C, Makuch RW, et al. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection . N Engl J Med 1989;;321:1791-6.
Connor E, Bagarazzi M, McSherry G, et al. Clinical and laboratory correlates of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus . JAMA 1991;;265:1693-1697.
Krasinski K, Borkowsky W, Holzman RS. Prognosis of human immunodeficiency virus infection in children and adolescents . Pediatr Infect Dis J 1989;;8:216-20.
Blanche S, Tardieu M, Duliege A-M, et al. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection . Am J Dis Child 1990;;144:1210-5.
Hsu H, Kunches L, Ng P, et al. Pneumocystis carinii pneumonia in infants with HIV infection . (Abstract 417) 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, GA, 1990 .
Kovacs A, Church J, Mascola L, et al. CD4 counts as predictors of Pneumocystis carinii pneumonia in infants and children with HIV infection . JAMA 1991;;265:1698-1703.
Bernstein LJ, Bye MR, Rubinstein A. Prognostic factors and life expectancy in children with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia . Am J Dis Child 1989;;143:775-8.
Vernon DD, Holzman BH, Lewis P, et al. Respiratory failure in children with acquired immunodeficiency syndrome and acquired immunodeficiency syndrome-related complex . Pediatrics 1988;; 82:223-8.
Pahwa S. Human immunodeficiency virus infection in children: nature of immunodeficiency, clinical spectrum and management . Pediatr Infect Dis J 1988;;7:S61-71.
Rogers MF, Ou CY, Kilbourne B, et al. Advances and problems in the diagnosis of HIV infection in infants . In: Pizzo PA, Wilfert CM, eds. Pediatric AIDS—The Challenge of HIV Infection in Infants, Children and Adolescents . Baltimore, MD: Williams & Wilkins, 1990;:159-74.
Roilides E, Clerici M, DePalma L, Rubin M, Pizzo PA, Shearer GM. T helper cell responses in children infected with human immunodeficiency virus type 1 . J Pediatr 1991; (in press).
Masur H, Ognibene F, Yarchoan R, et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection . Ann Intern Med 1989;;111:223-31.
Yanase Y, Tango T, Okumura K, et al. Lymphocyte subsets identified by monoclonal antibodies in healthy children . Pediatr Res 1986;;20:1147-51.
Denny TN, Niven P, Skuza C, et al. Age-related changes of lymphocyte phenotypes in healthy children . (Abstract 916) Pediatr Res 1990;;27:155A.
Leibovitz E, Rigaud M, Pollack H, et al. Pneumocystis carinii pneumonia in infants infected with the human immunodeficiency virus with more than 450 CD4 T lymphocytes per cubic millimeter . N Engl J Med 1990;;323:531-3.
Sanders-Laufer D, Burroughs M, Marshall F, et al. Pneumocystis carinii pneumonia (PCP) in "low-risk" HIV infected children (Abstract 108) Pediatr Res 1990;;27:183a.
Scott G, Buck BE, Leterman JG, et al. Acquired immunodeficiency syndrome in infants . N Engl J Med 1984;;310:76-81.
Fischl MA, Dickinson GM, La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS . JAMA 1988;;259:1185-9.
Hughes WT, Kuhn S, Chaudhary S, et al. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis . N Engl J Med 1977;;297:1419-26.
Hughes WT, Rivera GK, Schell MJ, et al. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis . N Engl J Med 1987;;316:1627-32.
Gutman LT. The use of trimethoprim-sulfamethoxazole in children: a review of adverse reactions and indications . Pediatr Infect Dis J 1984;;3:349-57.
Girdwood RH. The nature of possible adverse reactions to co-trimoxazole . Scand J Infect Dis 1976;;(
(Suppl 8)
):10-17.
Asmar BI, Maqbool S, Dajani AS. Hematologic abnormalities after oral trimethoprim-sulfamethoxazole therapy in children . Am J Dis Child 1980;;135:1100-3.
Lawson DH, Paice BJ. Adverse reactions to trimethoprim-sulfamethoxazole . Rev Infect Dis 1982;;4:429-33.
Jick H. Adverse reactions to trimethoprim-sulphamethoxazole in hospitalized patients . Rev Infect Dis 1982;;4:426-8.
Gordin FM, Simon GL, Wofsy CB, et al. Adverse reactions to trimethoprim-sulphamethoxazole in patients with the acquired immunodeficiency syndrome . Ann Intern Med 1984;;100:495-9.
Jaffe HS, Abrams DI, Ammann AJ, et al. Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men . Lancet 1983;;2:1109-11.
McSherry G, Wright M, Oleske J, et al. Frequency of serious adverse reactions to trimethoprim-sulfamethoxazole and pentamidine among children with human immunodeficiency virus 1 infection . (Abstract 1357) International Conference on Antimicrobial Agents and Chemotherapy, Los Angeles, CA, 1988 .
Leoung GS, Feigal DW, Montgomery AB, et al. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia . N Engl J Med 1990;;323:669-75.
Corkery KJ, Luce JM, Montgomery AB. Aerosolized pentamidine for treatment and prophylaxis of Pneumocystis carinii pneumonia: an update . Resp Care 1988;;33:676-85.
Diagnostic and therapeutic technology assessment (DATTA). Prophylactic treatment for opportunistic infections in HIV-positive patients: aerosolized pentamidine . JAMA 1990;;263:2510-4.
Martinez CM, Romanelli A, Mullen MP, et al. Spontaneous pneumothoraces in AIDS patients receiving aerosolized pentamidine . (Letter) Chest 1988;;94:1317-8.
Berger TG, Tappero JW, Leoung GS, et al. Aerosolized pentamidine and cutaneous eruptions . (Letter) Ann Intern Med 1989;;110:1035-6.
Lindley DA, Schleupner CJ. Aerosolized pentamidine and conjunctivitis . (Letter) Ann Intern Med 1988;;108:988.
Herer B, Chinet T, Labrune S, et al. Pancreatitis associated with pentamidine by aerosol . (Letter) Br Med J 1989;;298:605.
Hart CC. Aerosolized pentamidine and pancreatitis . (Letter) Ann Intern Med 1989;;111:691.
Chapelon C, Raguin G, De Gennes C. Renal insufficiency with nebulised pentamidine . (Letter) Lancet 1989;;2:1045-6.
Karboski JA, Godley PJ. Inhaled pentamidine and hypoglycemia . (Letter) Ann Intern Med 1988;;108:490.
Armstrong D, Bernard E. Aerosolized pentamidine for the prevention and treatment of pneumocystosis . AIDS Updates 1990;3:1-7.
Abd AG, Nierman DM, Ilowite JS, et al. Bilateral upper lobe Pneumocystis carinii pneumonia in a patient receiving inhaled pentamidine prophylaxis . Chest 1988;;94:329-31.
Jules-Elysee KM, Stover DE, Zaman MB, et al. Aerosolized pentamidine: effect on diagnosis and presentation of Pneumocystis carinii pneumonia . Ann Intern Med 1990;;112:750-7.
Northfelt DW. Extrapulmonary pneumocystosis in patients taking aerosolized pentamidine . (Letter) Lancet 1989;;2:1454.
Problete RB, Rodriquez K, Foust RT, et al. Pneumocystis carinii hepatitis in the acquired immunodeficiency syndrome (AIDS) . (Letter) Ann Intern Med 1989;;110:737-8.
Northfelt DW, Hardy WD. Aerosolized pentamidine and disseminated infection with Pneumocystis carinii . (Letter) Ann Intern Med 1989;;111:442-3.
Sparling TG, Dong SR, Hegedus C, et al. Aerosolized pentamidine and disseminated infection with Pneumocystis carinii . (Letter) Ann Intern Med 1989;;111:442.
CDC. Advisory committee for the elimination of tuberculosis: tuberculosis and human immunodeficiency virus infection: recommendations . MMWR 1989;;38:236-50.
CDC. Mycobacterium tuberculosis: transmission in a health clinic—Florida, 1988 . MMWR 1989;;38:256-8,263-4.
Metroka CE, Jacober D, Lewis N. Successful chemoprophylaxis for pneumocystis with dapsone or bactrim (Abstract T.B.O. 4) V International Conference on AIDS, Montreal, 1989 .
Torres R, Newlands J, Ortiz M, et al. Randomized trial of intermittent dapsone versus aerosolized pentamidine for primary and secondary prophylaxis of PCP . (Abstract Th.B. 407) VI International AIDS Conference, San Francisco 1990 .
Salvin M, Hoy JF, Mijch AM, et al. An open, randomized, prospective comparison of oral dapsone and nebulized pentamidine for PCP prophylaxis . (Abstract Th.B. 409) VI International AIDS Conference, San Francisco 1990 .
Kemper CA, Tucker RM, Lange OS, et al. Low-dose dapsone prophylaxis of Pneumocystis carinii pneumonia in AIDS and AIDS-related complex . AIDS 1990;;4:1145-8.
Hughes WT, Kennedy W, Dugdale M, et al. Prevention of Pneumocystis carinii pneumonitis in AIDS patients with weekly dapsone . (Letter) Lancet 1990;;2:1066.
Physician's Desk Reference , 45th Edition. Medical Economics Data, Oradell, NJ, 1991;:1107-8.
Tomecki KJ, Catalano CJ. Dapsone hypersensitivity: sulfone syndrome revisited . Arch Dermatol 1981;;117:38-9.
Donnelly H, Bernard EM, Rothkotter H, et al. Distribution of pentamidine in patients with AIDS . J Infect Dis 1988;;157:985-9.
Winslow D, Bincski A, Lincoln P, et al. Secondary prophylaxis of Pneumocystis carinii pneumonia with systemic pentamidine . (Abstract T.B.P. 45) V International Conference on AIDS, Montreal 1989 .
Karaffa C, Rehm S, Calabrese L. Efficacy of monthly pentamidine infusion in preventing recurrent Pneumocystis carinii pneumonia in AIDS patients . (Abstract 690). 26th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, 1986 .
Miller S, Lifris D. Efficacy of intramuscular pentamidine in the prophylaxis of recurrent Pneumocystis carinii pneumonia . (Abstract T.B.P. 60) V International Conference on AIDS, Montreal, 1989 .
Cheung T, Matta R, Neibart E, et al. Intramuscular pentamidine for Pneumocystis carinii pneumonia prophylaxis . (Abstract 1) AIDS Clinical Trial Group Meeting, Washington, DC, November 1990 .
Institute of Medicine Committee on Prenatal and Newborn Screening for HIV infection. HIV screening of pregnant women and newborns . Washington, DC: National Academy Press, 1991;.
Lewin EB. Role of trimethoprim sulfamethoxazole in prophylaxis of recurrent otitis media . Pediatr Infect Dis J 1989;;8:730-1. 669-75.